Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

• Egile Nagusiak: Minglu Liu (Egilea), Tong Hu (Egilea), Wenfeng Gou (Egilea), Huajie Chang (Egilea), Yanli Li (Egilea), Yiliang Li (Egilea), Daiying Zuo (Egilea), Wenbin Hou (Egilea), Shunchang Jiao (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Icaritin is a natural product with a wide range of anti-tumor effects. However, its anti-tumor mechanism has not been thoroughly studied. This study examined the inhibitory effect of icaritin on nasopharyngeal cancer and its underlying mechanism using network pharmacology along with in v...